SK8442000A3 - Hetorocyclic compounds, method for the preparation thereof, pharmaceutical composition comprising the same and their use - Google Patents
Hetorocyclic compounds, method for the preparation thereof, pharmaceutical composition comprising the same and their use Download PDFInfo
- Publication number
- SK8442000A3 SK8442000A3 SK844-2000A SK8442000A SK8442000A3 SK 8442000 A3 SK8442000 A3 SK 8442000A3 SK 8442000 A SK8442000 A SK 8442000A SK 8442000 A3 SK8442000 A3 SK 8442000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- pyridyl
- yloxy
- butyl
- dione
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9704546A SE9704546D0 (sv) | 1997-12-05 | 1997-12-05 | Novel compounds |
| PCT/SE1998/002190 WO1999029686A1 (en) | 1997-12-05 | 1998-12-01 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK8442000A3 true SK8442000A3 (en) | 2001-01-18 |
Family
ID=20409283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK844-2000A SK8442000A3 (en) | 1997-12-05 | 1998-12-01 | Hetorocyclic compounds, method for the preparation thereof, pharmaceutical composition comprising the same and their use |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1037889A1 (pt) |
| JP (1) | JP2001525406A (pt) |
| KR (1) | KR20010032800A (pt) |
| CN (1) | CN1284074A (pt) |
| AU (1) | AU1791599A (pt) |
| BR (1) | BR9813378A (pt) |
| CA (1) | CA2312357A1 (pt) |
| EE (1) | EE200000321A (pt) |
| HU (1) | HUP0100731A3 (pt) |
| IL (1) | IL136368A0 (pt) |
| NO (1) | NO20002787L (pt) |
| PL (1) | PL340837A1 (pt) |
| SE (1) | SE9704546D0 (pt) |
| SK (1) | SK8442000A3 (pt) |
| TR (1) | TR200001544T2 (pt) |
| WO (1) | WO1999029686A1 (pt) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9901875D0 (sv) | 1999-05-25 | 1999-05-25 | Astra Pharma Prod | Novel compounds |
| SE9904505D0 (sv) | 1999-12-09 | 1999-12-09 | Astra Pharma Prod | Novel compounds |
| TWI258462B (en) | 1999-12-17 | 2006-07-21 | Astrazeneca Ab | Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same |
| SE9904652D0 (sv) * | 1999-12-17 | 1999-12-17 | Astra Pharma Prod | Novel Compounds |
| JP2002330787A (ja) * | 2000-10-21 | 2002-11-19 | Astrazeneca Ab | 化学物質 |
| PA8557501A1 (es) | 2001-11-12 | 2003-06-30 | Pfizer Prod Inc | Benzamida, heteroarilamida y amidas inversas |
| WO2003042190A1 (en) | 2001-11-12 | 2003-05-22 | Pfizer Products Inc. | N-alkyl-adamantyl derivatives as p2x7-receptor antagonists |
| US7071223B1 (en) | 2002-12-31 | 2006-07-04 | Pfizer, Inc. | Benzamide inhibitors of the P2X7 receptor |
| PA8591801A1 (es) | 2002-12-31 | 2004-07-26 | Pfizer Prod Inc | Inhibidores benzamidicos del receptor p2x7. |
| WO2004099146A1 (en) | 2003-05-12 | 2004-11-18 | Pfizer Products Inc. | Benzamide inhibitors of the p2x7 receptor |
| GB0324498D0 (en) | 2003-07-21 | 2003-11-26 | Aventis Pharma Inc | Heterocyclic compounds as P2X7 ion channel blockers |
| BRPI0512781A (pt) | 2004-06-29 | 2008-04-08 | Pfizer Prod Inc | método para preparação de derivados de 5-{4-(2-hidroxi-propil)-3,5-dioxo-4,5-diidro-3h-[1,2,4]tria zin-2-il}-benzamida através da desproteção dos precursores de protetores de hidroxila |
| JP5306986B2 (ja) | 2006-03-16 | 2013-10-02 | エボテック （ユーエス） インコーポレイテッド | Ｐ２ｘ７調節因子としてのビシクロへテロアリール化合物およびその使用 |
| US8546579B2 (en) | 2006-03-16 | 2013-10-01 | Evotec (Us) Inc. | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
| TWI464148B (zh) | 2006-03-16 | 2014-12-11 | Evotec Us Inc | 作為ｐ２ｘ7調節劑之雙環雜芳基化合物與其用途 |
| TW200813018A (en) | 2006-06-09 | 2008-03-16 | Astrazeneca Ab | Novel compounds |
| MX2009000117A (es) | 2006-07-06 | 2009-01-23 | Glaxo Group Ltd | N-fenilmetil-5-oxo-prolin-2-amidas sustituidas como antagonistas de receptores p2x7 y sus metodos de uso. |
| GB0613473D0 (en) * | 2006-07-06 | 2006-08-16 | Glaxo Group Ltd | Novel compounds |
| DK2124562T3 (en) | 2007-03-09 | 2016-08-01 | Second Genome Inc | BICYCLOHETEROARYLFORBINDELSER AS P2X7 modulators and uses thereof |
| WO2008116845A1 (en) * | 2007-03-28 | 2008-10-02 | Glaxo Group Limited | Piperidinone carboxamide derivatives as p2x7 modulators |
| EP2139875A2 (en) * | 2007-03-29 | 2010-01-06 | Glaxo Group Limited | Oxazolidine and morpholine carboxamide derivatives as p2x7 modulators |
| KR20090127435A (ko) | 2007-04-03 | 2009-12-11 | 글락소 그룹 리미티드 | Ｐ2ｘ7 조절제로서의 이미다졸리딘 카르복스아미드 유도체 |
| US8119661B2 (en) | 2007-09-11 | 2012-02-21 | Astrazeneca Ab | Piperidine derivatives and their use as muscarinic receptor modulators |
| GB0803729D0 (en) * | 2008-02-29 | 2008-04-09 | Ge Healthcare Ltd | Imaging the central nervous system |
| ATE494926T1 (de) | 2008-03-25 | 2011-01-15 | Affectis Pharmaceuticals Ag | Neuartige p2x7r-antagonisten und ihre verwendung |
| MX2011010810A (es) | 2009-04-14 | 2012-01-12 | Affectis Pharmaceuticals Ag | Nuevos antagonistas de p2x7r y su uso. |
| EP2322149A1 (en) | 2009-11-03 | 2011-05-18 | Universidad del Pais Vasco | Methods and compositions for the treatment of ischemia |
| EP2386541A1 (en) | 2010-05-14 | 2011-11-16 | Affectis Pharmaceuticals AG | Novel methods for the preparation of P2X7R antagonists |
| WO2012110190A1 (en) | 2011-02-17 | 2012-08-23 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| WO2012163792A1 (en) | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| WO2012163456A1 (en) | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| JP7337083B2 (ja) | 2017-11-21 | 2023-09-01 | スリーエム イノベイティブ プロパティズ カンパニー | 口腔用植物系水中油型エマルジョン及び使用方法 |
| AU2018392886B2 (en) | 2017-12-20 | 2021-12-23 | Solventum Intellectual Properties Company | Oral compositions and methods of use |
| EP3727326A2 (en) | 2017-12-20 | 2020-10-28 | 3M Innovative Properties Company | Oral compositions and methods of use |
-
1997
- 1997-12-05 SE SE9704546A patent/SE9704546D0/xx unknown
-
1998
- 1998-12-01 HU HU0100731A patent/HUP0100731A3/hu unknown
- 1998-12-01 CA CA002312357A patent/CA2312357A1/en not_active Abandoned
- 1998-12-01 AU AU17915/99A patent/AU1791599A/en not_active Abandoned
- 1998-12-01 CN CN98813490A patent/CN1284074A/zh active Pending
- 1998-12-01 WO PCT/SE1998/002190 patent/WO1999029686A1/en not_active Application Discontinuation
- 1998-12-01 EE EEP200000321A patent/EE200000321A/xx unknown
- 1998-12-01 IL IL13636898A patent/IL136368A0/xx unknown
- 1998-12-01 BR BR9813378-0A patent/BR9813378A/pt not_active Application Discontinuation
- 1998-12-01 SK SK844-2000A patent/SK8442000A3/sk unknown
- 1998-12-01 TR TR2000/01544T patent/TR200001544T2/xx unknown
- 1998-12-01 KR KR1020007006117A patent/KR20010032800A/ko not_active Application Discontinuation
- 1998-12-01 PL PL98340837A patent/PL340837A1/xx unknown
- 1998-12-01 JP JP2000524280A patent/JP2001525406A/ja not_active Withdrawn
- 1998-12-01 EP EP98962753A patent/EP1037889A1/en not_active Withdrawn
-
2000
- 2000-05-31 NO NO20002787A patent/NO20002787L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20002787L (no) | 2000-08-01 |
| IL136368A0 (en) | 2001-06-14 |
| CN1284074A (zh) | 2001-02-14 |
| NO20002787D0 (no) | 2000-05-31 |
| HUP0100731A3 (en) | 2002-08-28 |
| KR20010032800A (ko) | 2001-04-25 |
| BR9813378A (pt) | 2000-10-10 |
| JP2001525406A (ja) | 2001-12-11 |
| AU1791599A (en) | 1999-06-28 |
| TR200001544T2 (tr) | 2000-11-21 |
| SE9704546D0 (sv) | 1997-12-05 |
| PL340837A1 (en) | 2001-02-26 |
| CA2312357A1 (en) | 1999-06-17 |
| WO1999029686A1 (en) | 1999-06-17 |
| EP1037889A1 (en) | 2000-09-27 |
| EE200000321A (et) | 2001-08-15 |
| HUP0100731A2 (hu) | 2002-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK8442000A3 (en) | Hetorocyclic compounds, method for the preparation thereof, pharmaceutical composition comprising the same and their use | |
| EP3661921B1 (en) | Selective inhibitors of nlrp3 inflammasome | |
| AU2006207300B2 (en) | Substituted triazole derivatives as oxytocin antagonists | |
| US8901307B2 (en) | Chemical compounds 251 | |
| US7456164B2 (en) | 3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands | |
| NL1028968C2 (nl) | 3- of 4-monogesubstitueerde fenol- en thiofenolderivaten die als H3-liganden bruikbaar zijn. | |
| EP1716135B1 (en) | Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists | |
| JP6453231B2 (ja) | ウレア誘導体、またはその薬理学的に許容される塩 | |
| US7649002B2 (en) | (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists | |
| TW202222794A (zh) | 醚化合物及其用途 | |
| CN105916852B (zh) | 作为RORc调节剂的芳基磺内酰胺衍生物 | |
| JP6746613B2 (ja) | ウレア誘導体、またはその薬理学的に許容される塩 | |
| EP3634955B1 (en) | Piperidinone formyl peptide 2 receptor agonists | |
| US10934282B2 (en) | Heteroaromatic modulators of the retinoid-related orphan receptor gamma | |
| EP3971176A1 (en) | Aromatic amine ar and bet targeting protein degradation chimera compound and use | |
| US11584736B2 (en) | Heterocyclic P2Y14 receptor antagonists | |
| US10774074B2 (en) | 2-(1-heteroarylpiperazin-4-yl)methyl-1,4-benzodioxane derivatives as alpha2C antagonists | |
| US20230416237A1 (en) | Amide compound, pharmaceutical composition and use thereof | |
| JP2022534704A (ja) | オレキシンアンタゴニストとしてのイミダゾロ誘導体、組成物、及び方法 | |
| MXPA00005327A (en) | Novel compounds | |
| Jacobson et al. | Heterocyclic P2Y14 receptor antagonists | |
| TW202115023A (zh) | 新型細胞凋亡訊號調節激酶1抑制劑 | |
| NZ786241A (en) | 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists |